• Profile
Close

Can immunotherapy improve TB treatment?

American Thoracic Society News Feb 17, 2017

Can the addition of immunotherapy to standard antibiotic treatment improve tuberculosis therapy?

In a February issue of the American Journal of Respiratory Cell and Molecular Biology article, researchers report that in a mouse model of pulmonary tuberculosis, combining three clinically approved immunotherapy agents (all–trans–retinoic acid, 1,25(OH)2–vitamin D3, and alpha–galactosylceramide) with three antibiotics (isoniazid, rifampicin, and pyrazinamide) resulted in lower mycobacterial loads after five weeks of treatment and significantly reduced relapse after a 13–week course of treatment, compared to antibiotic treatment alone.

The researchers also analyzed cellular changes and cytokine expression and found that mice being treated with immunotherapy as well as antibiotics showed reduced accumulation of immature myeloid cells in the lungs and increased TNF–alpha protein levels.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay